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1. Introduction  
Distal symmetrical polyneuropathy is the most common form of neurological complications 
in diabetes mellitus (DM). It is sensory-motor polyneuropathy dominated by sensitive 
symptoms and signs, primarily decrease or loss of sensibility in distal parts of extremities, or 
positive symptoms of prickling, burning pain and tingling. These symptoms can be 
extremely unpleasant for patients but at the same time they are a huge therapeutic problem 
as well. Motor symptoms and signs in early phase of DSP are often absent, although by 
neurophysiologic tests motor fibers damaging signs can be detected and this damage often 
leads to loss of functions in patients in advanced phase of the disease. The most significant 
clinical consequence of sensitive and autonomic fibers damage is feet ulceration, what is a 
leading cause for hospitalization and for lower extremities amputations, if trauma factors 
are excluded. Thus, diabetic DSP is important not only for clinical reasons but for economic 
ones as well, especially regarding the fact that DM prevalence is rapidly growing. For many 
years scientists have done numerous researches for therapeutic solutions to prevent, delay 
or slow the progression of the disease, aiming to better understanding of ethiopathogenesis 
of this disease. Special attention has been paid to oxidative stress (OS) role in pathogenesis 
of DM and diabetic neuropathy. Despite numerous experimental confirmations of OS in 
diabetic patients, there is still controversy about whether oxidative stress is just a side effect 
or it is a possible cause of diabetic neuropathy. More than thousand studies about this 
problem have already been reported and since this problem is not completely solved, 
further investigations are required. Therefore, a good knowledge of biochemistry of 
oxidative stress, cell signal transduction and  antioxidative protection is necessary. 
2. Biochemistry of oxidative stress 
Oxidative stress is a consequence of the imbalance between reactive oxygen species (ROS) 
production and antioxidant capacity. This can occur as a result of either increased ROS 
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generation, impaired antioxidant system, or a combination of both. Free radicals are defined 
as an atoms or molecules that contain one or more unpaired electrons, making them 
unstable and highly reactive (Halliwell , 1999). The most important free radicals are reactive 
oxygen species (ROS) and reactive nitrogen species (RNS). ROS include free radicals such as 
superoxide (O2-), hydroxyl (OH), peroxyl (RO2), hydroperoxyl (HRO2-) as well as nonradical 
species such as hydrogen peroxide (H2O2) and hydrochlorous acid (HOCl) (Turko et al., 
2001; Evans et al., 2002; Ziegler, 1994; Soliman & Gellido,2004.). Other non-oxygen species 
existing as reactive nitrogen species (RNS) include free radicals like nitric oxide (NO) and 
nitrogen dioxide (NO2-), as well as nonradicals such as peroxynitrite (ONOO-), nitrous oxide 
(HNO2) and alkyl peroxynitrates (RONOO) (Ziegler, 1994; Soliman and  Gellido,2004).  
In aerobic cells, free radicals are constantly produced mostly as reactive oxygen species. 
Once produced, free radicals are removed by antioxidants defenses including enzyme 
superoxide dismutase, catalase and gluthation peroxidise. Reactive oxygen species, 
including nitric oxide and related species, commonly exert a series of useful physiological 
effects. However, imbalance between prooxidant and antioxidant defenses in favour of 
prooxidants results in oxidative stress associated with the oxidative modification of 
biomolecules such as lipids, proteins and nucleic acids.  
Hyperglycemia is the main cause of increased concentration of free radicals in the plasma of 
diabetic patients. 
Chronic hyperglycemia causes oxidative stress (OS) in a number of ways including 
enzymatic,  non-enzymatic and mitochondrial pathways,  thus disrupting the 
prooxidative/antioxidative balance in cellular systems. 
Nonenzymatic sources of oxidative stress originate from the oxidative biochemistry of 
glucose. Hperglycemia can directly cause increased ROS generation. Glucose can undergo 
autoxidation and generate OH radicals. A second consequence of hyperglycemia is 
nonenzymatic glycation of proteins.    
Nonenzymatic glycation of proteins implies the ability of glucose to react in a nonenzymatic 
process with proteins, reducing molecular oxygen to highly reactive products (superoxide 
radical, hydrogen peroxide, and hydroxyl radical). The glycation process occurs in two 
phases: early – reversible, and late – irreversible phase. The early phase is characterized by 
the development of Amadori products followed by formation of stable adducts - advanced 
glycation end products (AGEs) in the later phase. The production of intracellular AGE 
precursors damages target cells via three pathways. First, intracellular proteins, modified by 
AGE, alter their own function. Second, extracellular matrix components modified by AGEP 
precursors interact abnormally with other matrix components and with matrix protein 
receptors on the cells. Third, plasma proteins modified by AGE precursors bind to the AGE 
receptors on endothelial cells, mesangial cells, and macrophages, causing receptor-mediated 
production of reactive oxygen species (ROS). 
Enzymatic sources of augmented generation of reactive species in diabetes include NOS, 
NAD(P)H oxidase and xanthine oxidase (Guzik et al.,2000; Guzik et al., 2002; Aliciguzel et 
al.,2003) , where it is considered that the NAD(P)H oxidase is the major source of 
O2−productionf (Guzik, 2000; Ergul et al., 2004).  
The mitochondrial respiratory chain is another source of nonenzymatic generation of 
reactive species. Hyperglycemia-induced generation of O2- at the mitochondrial level is the 
initial trigger of vicious cycle of oxidative stress in diabetes (Schultz et al., 2005, Nishikawa 
et al., 2000, Brownlee, 2001). Iincreased generation of ROS,  especially O2- precedes the 
activation of four major pathways involved in the development of diabetic complications. 
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In hyperglicemia there is enhanced metabolism of glucose through the polyol (sorbitol) 
pathway, which also results in inhanced productions of O2-. Glucose is a poor substrate for 
aldose reductase, but at high concentrations this enzyme converts glucose to sorbitole, 
initiating the polyol pathway of glucose conversion to fructose. 
This pathway of glucose metabolism implies the participation of aldosoreductase enzyme, 
which using the NADPH cofactor, catalyzes the reduction of glucose into sorbitol, which 
can be further transformed into fructose. Aldosoreductase is widespread in the mammalian 
tissues such as peripheral nerves, retina, renal glomeruli, eye lenses. Stimulation of this 
pathway in hyperglycemic conditions is one of the pathogenetic mechanisms responsible for 
the development of diabetic neuropathy, nephropathy, and cataract. Activation of this 
pathway leads to structural changes in the tissues via several mechanisms, out of which 
most significant are increased osmotic pressure in the cell, depletion of myoinositol, and 
disordered redox potential of the cell due to reduced NADPH concentration, on the account 
of which the activity of NADPH dependent enzymes (including glutathione reductase and 
NO synthase) is diminished. Reduced production of NO leads to vasoconstriction, and 
impossibility of reduced glutathione regeneration in the so called glutathione redox cycle 
leads to depletion of reduced glutathione, since it is regenerated by the action of NADPH-
dependent glutathione reductase (Garlberg & Mannervik, 1975), ultimately producing a 
permanent oxidative stress. Change of redox status of the cell, as determined by the cellular 
content of thiol compounds, glutathione above all, is a significant factor in the regulation of 
signal transduction to appropriate genes. This signal transduction pathway is effectuated 
via so called redox sensors which react to any change of concentration of intracellular thiols 
responsible for upkeeping of the cellular redox status. Numerous regulatory transcription 
factors supress transcription if bound in reduced state to regulatory sequences of certain 
genes. In the absence of GSH in the cell and in the state of intensified polyol metabolic 
pathway, the oxidized form of regulatory nuclear transcription factors loses the affinity for 
regulatory gene sequence, which results in increased transcription and synthesis of 
appropriate functional and structural proteins responsible for complications in diabetes and 
dysregulation of glucose metabolism homeostasis. Disturbed redox potential initiates the 
activation of stress-signaling cascade, resulting in direct activation of other kinases and 
transcription factors and/or indirect modulation (oxidation) of cysteine-rich redox-sensitive 
proteins, such as thioredoxin and glutathione S-transferase (Adler et al., 1999). 
2.1 Modulation of cell signal transduction  
Results of recent clinical and experimental in vivo and in vitro studies unequivocally suggest 
that DM is a disease followed by intensified oxidative stress which modulates numerous cell 
transduction pathways (Pavlović et al.,2002;Tomlinson & Gardiner,2008). This eventually 
results in tissue damage and the emergence of numerous diabetic complications,  including 
peripheral neuropathy.  
Hyperglycemia leading to oxidative stress induces diabetic complications via two signaling 
pathways: activation of protein kinase C (PKC) (Tomkin, 2001), and activation of mitogen-
activated protein kinases  (MAPK) (Tomlinson, 1999).  PKC represents a family of 
multifunctional enzymes synthesized on at least three separate genes. They play a 
fundamental role in signal transduction in various tissues via phosphorylation (up and 
down regulation) of enzymes, receptors, transcription factors, and other kinases. PKC family 
consists of at least 11 isoforms, out of which 9 are activated by way of lipid secondary 
www.intechopen.com
 
Role of the Adipocyte in Development of Type 2 Diabetes 
 
156 
messenger diacylglycerol (DAG). High glucose concentration increases the level of DAG 
stimulating de novo synthesis of DAG, which activates PKC. Hyperglycemia can also 
activate PKC isoforms via AGE receptors (Portilla et al., 2000) and by increased activity of 
the polyol pathway (Keogh, Dunlop & Larkins,1997.), probably by incresing reactive oxygen 
species (ROS). Intensified DAG-PKC signaling pathway is responsible for the disorders 
which represent the basic mechanisms in the development of vascular complications in 
diabetes mellitus. 
In the complex process of signal transduction there are interactions of numerous receptor 
proteins and impulses are being amplified, so that joint, cascade pathways of signal 
transduction may be talked about. One of these pathways is the PKC-MAPK signal 
transduction pathway (Tomlinson & Gardiner,2008). Specific isoforms of PKC can activate 
MAPK, which via phosphorylation of transcription factors lead to altered expression of 
certain genes, making conditions for the change of cellular phenotype, apoptosis, or survival 
with a resultant disbalance producing complications in particular organs and systems. Thus 
MAPK activation represents a key event in the development of diabetic complications, 
especially diabetic neuropathy. Activation of this signaling pathway induces changes at the 
level of ion channels or disturbed gene expression, directly leading to nerve conduction 
disorders and development of axonopathy. 
MAP kinases  are group of serin/threonine specific kinases which are activated in response 
to extracellular stimuli through dual phosphorylation at conserved threonine and tyrosine 
residues.   There are three main groups of MAP kinases: extracellular signal-regulated 
protein kinases (ERK), p38 and c-Jun N-terminal kinases (JNK). Results of recent clinical and 
experimental in vivo and in vitro studies show that all three groups of MAP kinases are 
activated in sensory neurons in hyperglicemia conditions in both diabetic rats and patients. 
(Purves at al, 2001) . In general the JNK and p38 group mediate responses to osmotic stress 
and is likely to be involved in the regulation of aldose reductase expression . Activation of 
p38 MAPK results in generating reduced nerve conduction velocity (NCV). These changes 
in NCV results from phosphorilation of the sodium channel Na 1.6 (Wittmack et al., 2005), 
which is the main voltage-activated channel at the node of Ranvier in myelinated fibres. In 
later stages of DM, other factors prevail:  neurofilaments  perturbation occurs, as a result of 
JNK activation and hyperphosphorylation of neurofilament proteins. 
2.2 Antioxidant protection
 
The biological oxidative effects of free radicals on macromolecules are controlled by a 
spectrum of enzymatic and nonenzymatic antioxidants. Intracellular antioxidative defense is 
primarily enabled by the antioxidative enzymes,  most significant of which are SOD,  CAT 
and GSH-Px (Andrea et al.,2004; Maritim et al., 2003; Szaleczky et al., 1999; Djordjević, 2004). 
These three antioxidant enzymes differ in their structure, tissue distribution and cofactors 
required for functioning. SOD works as the first line of enzymatic protection against 
superoxide radicals. This enzyme catalyses the dismutation of superoxide anion radicals 
into hydrogen peroxide and oxygen. Hydrogen peroxide is further metabolized by CAT and 
GSH-Px,  and  due to lower Km values,  GSH-Px is active in lower concentrations of 
hydrogen peroxide,  while CAT activity increases with increased hydrogen peroxide 
concentration (Djordjević, 2004; Djordjević et al.,2000). Glutathione, together with its related 
enzymes, comprises a system that maintains the intracellular reducing environment and acts 
as primary defense against excessive generation of harmful ROS. 
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During reduced antioxidative protection and/or increased production of free radicals,  OS 
occurs, playing an important role as a mediator of the apoptosis of  both neurons and 
supportive glial cells,  which has been confirmed in studies using animal models and tissue 
cultures (Schmeichel et al.,2003; Russel et al., 1999;Russel et al., 2002; Polydefkis et al., 2003; 
Person et al., 2003; Chiarelli et al., 2000; Sakaue et al., 2003). 
2.2.1 Superoxide dismutase (SOD) 
SOD catalyzes the conversion of superoxide anion into hydrogen peroxide and oxygen. 
O2− + O2− + 2H+ → H2O2 + O2 
SOD activity was originally described by McCord and Fridovich in 1969 (Szaleczky et al., 
1999); they subsequently established that this enzyme is essential in sustaining life in aerobic 
conditions (McCord et al.,1971). There are several forms of SOD. These are metalloproteins, 
each containing a metal ion in its center (CuZn SOD, Mn SOD, Fe SOD, and Ni SOD) 
(Fridovich,1998). Fe SOD can be found in procaryotes and plants, while in humans intra- 
and extracellular CuZn SOD as well as mitochondrial Mn SOD were identified. 
Intracellular CuZn is composed of two identical subunits (Tainer et al.,1982), each 
containing Cu (II) and Zn (II). Cu (II) is responsible for catalytic activity of SOD, while Zn 
(II) has a role in the stabilization of enzyme conformation (Djordjević, 2004). Cytosolic CuZn 
SOD can be inactivated by hydrogen peroxide, leading to the formation of either Cu (II) –
OH or the ionized form Cu (II) –O-. This enzyme can further catalyze peroxidation of 
various substances. The gene coding for CuZn SOD is located on chromosome 21. In 
connection with that, the results of some studies have demonstrated a significantly elevated 
activity of this enzyme in the patients with Down syndrome (Kurobe  et al.,1990). 
Extracellular SOD (ECSOD) is structurally similar to intracellular SOD, but it is present in 
the extracellular space. The gene for ECSOD is located on the chromosome 4. ECSOD is a 
tetrameric glycoprotein, each subunit of which contains a Cu and Zn atom and has a high 
affinity for heparin sulphate, enabling its existence in relatively high concentrations in 
specific regions of extracellular space or on the cell surface. ECSOD expression is principally 
regulated by cytokines, such as IFNǄ, which stimulates the enzyme expression, while TNFǂ 
and TGFǃ reduce its expression (Marklund,1992). Reduced ECSOD expression lead to 
reduced mitochondrial GSH and increased oxidative stress (Lebovitz RM et al.,1996). 
ECSOD is also significant in modulating NO activity. The superoxide can react with NO and 
form peroxynitrite, which by way of dissociation can form both hydroxil radical and nitric 
dioxyde, potent oxydants (Fukai T et all, 2000; Oury TD et al., 1996). 
Mitochondrial SOD (MnSOD) is located in the mitochondrial matrix. There are two isoforms 
of MnSOD, dimeric MnSOD and tetrameric MnSOD, each subunit of which contains one Mn 
(III) ion. It is produced in a constitutive manner, but can also be induced by IL-1, TNF, or an 
endotoxin (Tang et al.,1994). In addition to cytokines, numerous oxygen metabolites can also 
induce MnSOD expression in particular cell types, which can be of critical importance in the 
occurrence of tissue damage in the situation of oxidative stress (Djordjević, 2004; Yoshioka T 
et al.,1994). It is believed that transcriptional regulation of MnSOD is mediated by the 
activation of nuclear transcription factor κB (NF- κB), supported by oxidants. Congenital 
complete inactivity of MnSOD lead to lethal outcome within few days after birth due to 
renal dysfunction (Lebovitz RM et al.,1996). 
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2.2.2 Catalase (CAT) 
Catalase is a homotetrameric enzyme found in the tissues of almost all mammals, and 
demonstrating the highest activity in the liver and erythrocytes. Within the cell, catalase is 
localized primarily in the peroxisomes and mitochondria. The principal role of catalase lies 
in the degradation of H2O2, produced with support of peroxisomal oxidases. In the 
erythrocytes, catalase constitues the first line of defense against H2O2 (Mueller et al., 1997). 
In the situations of normal H2O2 concentration, the reaction goes towards H2O2 conversion 
into water and oxygen:  
Catalaza + 2 H2O2 → Compaund I + H2O 
Compaund I + H2O2 → Katalaza + H2O + O2  
The second H2O2 molecule serves as the donor of hydrogen ion. 
In the situations of low H2O2 concentration and in the presence of small molecular electron 
donors, catalase may act as peroxydase as well (Ghadermarzi & Moosavi-Movahedi,1996). 
Catalase forms a firm bond with NADPH, which can prevent the accumulation of inactive 
forms of the enzyme slowly created when catalase is exposed to hydrogen peroxide. These 
effects of NADPH are evident in low concentrations in the cell as well (<0.1 μM) (Kirkman 
et al., 1987). 
Numerous diseases can be accompanied with altered catalase activity. Reduced catalase 
activity has been documented in diabetes mellitus (DM), malignant diseases, Down 
syndrome, as well as in regenerating tissues and in experimental conditions of 
nephrotoxicity (Djordjević et al., 2000). Since catalase has a predominant role in the control 
of H2O2 concentration (Mueller et al., 1997; Gaetani et al., 1996), which has been shown to 
damage pancreatic ǃ cells and inhibits insulin activity (Murata et al.,1998; Tiedge et al., 1998; 
Jorns et al., 1999), it is believed that catalase in that manner protects ǃ cells from the harmful 
action of H2O2 (Murata et al.,1998). 
In the literature, two categories of genetic deficiency of erythrocyte catalase have been 
described (Eaton and Ma, 1995): acatalasemia (<10% of normal activity) and 
hypocatalasemia (about 50% of normal activity). In Hungary, a family with acatalasemia 
and 12 families with hypocatalasemia have been reported (Góth & Eaton, 2000; Góth, 1992; 
Vitai & Góth, 1997). These families comprised 2 acatalasemic individuals, 61 individuals had 
hypocatalasemia, while 66 individuals had normal values of catalase. In the group with 
hereditary catalase deficiency, the incidence of diabetes was 12.7%. DM was diagnosed in 8 
persons, in both acatalasemic and 6 persons with hypocatalasemia; all of them had DM type 
2. None of those with normal catalase values had DM. These data can indicate the 
significance of catalase in the pathogenesis of DM. 
2.2.3 Glutathione peroxidase (GSH-Px) 
GSH-Px is a selenium-dependent enzyme naturally occurring in three isoforms. The so 
called „classical“ GSH-Px is a homotetramer with a molecular mass of 80 kDa, containing 
four atoms of selenium. GSH-Px demonstrates a special affinity for hydrogen peroxide and 
glutathione (Djordjević, 2004). It reduces H2O2 and organic alkaline hydroperoxides into 
water and appropriate alcohols, and oxidizes GSH into an appropriate disulfide (GSSG). 
2GSH + H2O2 (ROOH) → GSSG + ROH +H2O 
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GSSG is converted back into GSH by glutathione reductase, which utilizes NADPH for its 
activity. It is thought that NAD(P)H, by itself, as an antioxidant, can act as a scavenger of 
toxic free radicals, as well as the radicals originating from repaired biomolecules (Kirsch and  
De Groot, 2001). The classical, selenium-dependent GSH-Pxs, isolated from various organs 
(erythrocytes, liver, lungs), demonstrate similar features and catalytic properties regardless 
of their origin. The maximum rate of reaction of GSH-Px depends on the concentrations of 
GSH and H2O2. In contrast to catalase, GSH-Px demonstrates a higher affinity for the 
substrate (H2O2) at low H2O2 concentrations, since the Michaelis constant (KM) of peroxidase 
is lower than that of catalase. That is why GSH-Px plays a key role in the tissue detoxication 
from H2O2 at low H2O2 concentrations and normal GSH concentrations, while catalase is 
actively involved at higher H2O2 concentrations in the cell. The role of GSH-Px in 
erythrocytes is predominantly associated with detoxification from organic hydroperoxides 
and with keeping in reduced state the SH groups of structural and functional erythrocyte 
proteins, while its role in H2O2 degradation is of a lesser significance compared to catalase. 
The activity of erythrocyte selenium-dependent GSH-Px correlates with the erythrocyte 
content of selenium, so that the activity of this enzyme can be used as a functional index to 
assess selenium deficiency. 
The second type of peroxidase is extracellular GSH-Px, with a molecular mass of 21.5 kDa. It 
is a tetramer too, the subunits of which contain an atom of selenium each. It is thought that 
extracellular GSH-Px is most important regarding the reduction of H2O2 in the plasma. 
GSH-Px in the plasma is a glycoprotein, believed to be most probably a secretory enzyme 
released from organ cells into the plasma. This enzyme demonstrates significant kinetic 
differences compared to erythrocyte GSH-Px. In contrast to erythrocyte GSH-Px, GSH-Px in 
the plasma demonstrates saturation kinetics compared to GSH (Đorđević et all, 2000). The 
activity of this enzyme declines with increased glutathione via the value of saturation 
concentration for GSH of 5 mmol. Moreover, GSH-Px in the plasma demonstrates higher 
affinity for organic hydroperoxides and H2O2. It is thought that selenium-dependent plasma 
GSH-Px is responsible for the process of detoxication from H2O2 and organic 
hydroperoxides created in the process of synthesis of eicosanoids in entothelial cells 
(Đorđević et all, 2000). Although the concentration of reduced glutathione in the plasma is 
very low, it is conceivable that the change in glutathione concentration (interorgan 
distribution, release from the liver into the plasma) can modulate the enzyme activity. 
The third type of peroxidase is phospholipid hydroperoxide GSH-Px (PHGpx). It is too a 
selenium-dependent enzyme which differs from the first two types in view of the substrate 
and localization. PHGpx is a monomer, with the molecular mass of 23 kDa. This enzyme has 
a special characteristic – it directly reduces lipid hydroperoxides in the membranes. 
Reduced GSH-Px activity can be found in numerous pathologic conditions and diseases, 
such as in chronic etilism, chronic renal insufficiency, hypertension, endemic nephropathy 
(Djordjević  et all 1998). Altered GSH-Px activity can also be detected in DM (Kaji et al., 
1985; Cser et al., 1993; Matkovics et al., 1982). 
GSH-Px activity in the nervous system is low (in both peripheral nerves and in the central 
nervous system). Low values of GSH-Px compared to catalase activity in the peripheral 
nerves could lead to the conclusion that this enzyme has a minor role in H2O2 inactivation. 
However, GSH-Px function is prominent in the mitochondria, where the enzyme is 
necessary for the inactivation of H2O2 generated during the electron transport (McClain and 
Crook , 1996) where the catalase activity is insufficient. 
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2.2.4 Glutathione (GSH) 
Glutathione is one of the most important nonenzymatic antioxidant in mammal cells. This 
ubiquitous tripeptide (Ǆ-Glu-Cys-Gly) accounts for 90% of total non-protein sulphydril 
compounds in the cell. In the cell, it is most commonly found as a thiol – in a reduced form – 
and less as a disulfide – in an oxidized form (Toyokuni, 1996; Hann et al., 1990; Natarajan, 
1995).  
GSH concentration in the cell is determined by the control of enzymes involved in its 
synthesis, availability of synthesis precursors, intensity of GSH depletion for cellular 
detoxification processes, interorgan GSH distribution, as well as GSH regeneration in the so 
called glutathione redox cycle. 
Erythrocytes represent a unique transport system for glutathione and its conjugates. In 
contrast to other cells, GSH appears in erythrocytes in several intermediary metabolic forms. 
In physiologic conditions, reduced GSH form appears in the highest percentage. The other 
GSH form is oxidized glutathione (GSSG), occurring in the process of nonenzymatic 
oxidation or oxidation mediated by GSH-peroxidase. The third erythrocyte form is the 
disulphide form of glutathione bound to proteins and non-protein sulphydril compounds. 
Glutathione S-conjugates (occurring via the action of glutathione S-transferase) are the 
fourth potential intracellular-intermediary form of GSH in the erythrocytes. Erythrocytes 
take up toxic molecules from the plasma, to be excreted back into plasma after conjugation 
with GSH. Further detoxification of S-conjugates continues in the liver and kidneys; non-
toxic compounds are then excreted from the organism via the bile or urine. 
GSH is involved in many cellular functions. Many cells synthesize GSH de novo by Ǆ-
glutamyl transferase, forming firstly a Ǆ-peptide bond between one cystein and one 
glutamate residue. The next phase is the addition of glycine, assisted by GSH synthetase. 
Neurons do not contain Ǆ-glutamyl-cystein synthetase; instead, GSH is synthesized in the 
glial cells controlling this synthesis via the mechanisms of transcription regulation (Iwata-
Ichikawa  et al., 1999; Keelan et al., 2001). It is thought that during the evolution, depending 
on the cellular metabolic needs, glutathione is engaged in the regulation of different 
processes. Though the role of glutathion has been commonly associated with the protection 
of the cell from active free radicals, glutathione is involved in many other processes such as 
detoxification from xenobiotics, synthesis of eicosanoids, synthesis of nucleic acids and 
proteins, cell signaling, proliferation, and differentiation (Djordjević,2000). However, its 
essential role lies in the protective antioxidant system. GSH, GSH-Px, GSH-transferase, 
GSH-reductase, and NAD(P)H constitute an antioxidant system of glutathione, in which 
GSH-reductase and NAD(P)H are required for the reduction of oxidized glutathione and 
consequential glutathione recycling in the so called glutathione redox cycle. Depletion of 
GSH in the cell increases its sensitivity to oxidative damage (Rizzardini et al., 2003). In 
contrast, accumulation of GSH in the cell, especially in the mitochondria, can prevent neural 
apoptosis caused by ischemia (Li et al., 2002) and excitotoxicity (Kobayashi et al., 2000). The 
involvement of GSH in the limitation of prooxidative cell status, has as the ultimate 
consequence deceleration of aging, atherogenesis, mutagenesis, and cancerogenesis 
(Anghileri and Thouvenot ,1997; Vostreis  et al., 1988)  
3. Aim of study 
Research in patients with diabetic neuropathy (DN) is mainly based on studying the 
influence of antioxidative substances on certain biomarkers of oxidative stress and on the 
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function of peripheral nerves (Ziegler et al., 1995; Reljanović et al., 1999; Ziegler et al., 1999; 
Ametov et al., 2003; Ziegler and Gries, 1997; Ziegler et al., 1997). However, there are no 
enough studies, testing the direct correlation between prooxidative/antioxidative 
parameters and the development of DN,  especially in humans. Additional difficulties occur 
when different kinds of reactive oxygen are directly determined in biological systems due to 
their short life. For this reason,  the measurement of oxidative stress is mainly based on 
indirect and non-specific measurement of products of their activity.  
Considering that antioxidant enzymes are important biomarkers of oxidative stress, the aim 
of this study was to determine the activities of antioxidant enzymes (SOD, CAT, GSH-Px)  
and glutathione in the erythrocytes of patients with type 2 diabetes mellitus (DM) in relation 
to presence or absence of distal symmetrical polyneuropathy  (DSP), as well as to analyze 
the possible connection between the activity of these antioxidant parameters and the 
function of peripheral nerves. In this way we tried to determine the level of antioxidant 
defense in erythrocytes of diabetic patients and to establish the potential role of oxidative 
stress in the development of diabetic neuropathy.  
4. Materials and methods  
The research took the form of a prospective study,  which included 100 patients suffering 
from type 2 DM and diabetic distal symmetric polyneuropathy (DDSP). Patients suffering 
from another acute or chronic illness,  patients previously subjected to cytotoxic therapy or 
radiotherapy,  and patients who had been treated with antioxidative substances were 
excluded from the experimental group. The control group gathered 50 healthy individuals 
who denied ailments and diseases and whose clinical observations and laboratory tests 
showed no abnormalities. The DDSP was diagnosed after clinical and electrophysiological 
testing.  
The electrophysiological testing checked the conductivity of sensory and motor fibers of 
upper and lower extremity peripheral nerves. Due to the symmetric nature of the disease,  
the protocol included the unilateral (right) testing of sural,  peroneal,  tibial,  ulnar and 
median nerves. We analyzed the latency,  amplitude,  and conduction velocity of the tested 
nerves. The minimal criterion for the electrophysiological validation of diabetic neuropathy 
(DN) was the abnormality of any electroneurographic (ENG) conduction parameter in at 
least two nerves,  one of which had to be sural nerve (England et al., 2005). The values of 
tested electroneurographic parameters were expressed as the score from 1 to 4,  where 1 
corresponded to a normal result,  while 4 meant that the motor or sensory evoked potential 
was absent. The ENG testing was carried out on the ENG device (Schwartzer,  Mios 2+). 
During the testing,  the surface electrodes were used: the stimulation electrode – for the 
electrical stimulation of the peripheral nerve and the registration electrode – for the 
registration of the motor evoked potential (MEP). In order to increase the diagnostic 
sensitivity of the electrophysiological tests,  in addition to the standard ENG,  we also tested 
the conduction sensitivity of the median plantar nerve. Since the sensory evoked potential 
(SEP) amplitude of medial plantar nerve is distinctly low,  a separate technique was used to 
test this on an evoked potential device (Medelec Sapphire 2). A large number (236) of 
stimuli were used and the values were subsequently averaged by the computer. The 
following parameters were analyzed: the peak latency of the sensory neurogram, expressed 
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in milliseconds,  and the amplitude of the sensory neurogram,  expressed in µV. The 
stimulation was carried out with a surface electrode positioned on the plantar part of the 
thumb. The response was registered via a surface electrode located behind the internal 
malleolus,  proximal to the retinaculum flexorum.  
Laboratory analysis determined the level of morning glycemia and glycosylated hemoglobin 
(HbA1c) by the standard laboratory tests from the venous blood of patients and halthy 
persons. Erythrocyte SOD activity was determined by a commercial test Ransod provided 
by Randox (Randox Laboratories,  Crumlin,  UK), based on the McCord and Fridovich 
method (Mccord and Fridovich, 1969). Erythrocyte CAT activity was determined by the 
method of Beutler (Beutler, 1982).  Erythrocyte GSH-Px  activity was determined by 
commercial test Ransel (Randox Laboratories, Crumlin, UK). Glutathione was measured as 
total glutathione in the erythrocytes as described by Tietze (1969).  Caiman′s GSH Assay kit 
utilizes a carefully optimized enzymatic recycling method, using glutathione reductase for 
quantification of GSH. 
Statistical method: To process results we used widely accepted statistical techniques: means 
and standard deviation,  statistical significance calculation tests,  correlation tests. We 
utilized standard statistics software tools (Origin Pro and MATLAB Statistics Toolbox). The 
results are presented as mean ± SD. 
5. Results 
The study encompassed 100 type 2 DM patients who showed signs of distal symmetrical 
polyneuropathy, whose average age was 58.62±11.62 years. The average duration of the 
disease was 11.32±7.05 years. The control group included 50 healthy individuals, whose 
average age was 51.64±12.25 years (Tab. 1). There was significant increase in glycemia and 
HbA1c values in the patients compared with the control group (*p<0. 0001). 
 
 Number Sex(M/F)
Age 
(years) 
mean ±SD 
Duration 
of  
DM 
(years)  
Glycemia 
(mmol/L) 
mean ±SD 
HbA1C 
(%) 
mean ±SD 
Control 50 22 / 28 51.64±12.25 0 4.81 ±0.63 5.73 ± 0.56 
Patients 
without 
DSP 
40 24 / 16 57.73±11.08 11.23±7.94 8.99±3.11* 
9.26 ± 
3.33* 
Patients 
with 
DSP 
100 55 / 45 58.62±11.62 11.32±7.05 9.50 ±4.13* 9.09 ±2.13* 
Table 1. Demographic and biochemical characteristics of diabetic neuropathy patients and 
the control group.  
There was a statistically significant decrease SOD and GSH-Px activity and GSH level in 
erythrocyte of diabetic neuropatrhy patients compared with the control group and patients 
without DN. The values of erythrocyte CAT were lower in patients compared to the control 
ones, but this difference did not reach statistical significance (Tab. 2). 
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SOD (U/gr 
Hb) 
mean ±SD 
CAT (U/gr 
Hb) 
mean ±SD 
GSH-Px(U/gr 
Hb) 
mean ±SD 
 GSH (µmol/grHb) 
mean ±SD 
 Control  1238.36 ± 136.86 7.34 ± 1.62 67.35 ± 11.39 0.24 ± 0.05 
Patients without 
DSP  
1144.26 ± 
103.92** 
7.22 ± 2.01 55.63 ±13.07** 0.22 ± 0.05** 
Patients with 
DSP  
1101.00 ± 
64.36**,* 6.68 ± 1.26 
50.25 ± 
10.42**,* 0.21 ± 0.04** 
 
 
 
Table 2. SOD and CAT in the diabetic neuropathy patients and in the control group. ** 
p<0,001  vs. control,   * p<0,05 vs. patients  without DN 
Values of antioxidant parameters were variable at different stages of the disease in patients 
with DDSP (Fig. 1-4). 
 
 
 
 
 
 
 
* p<0.05 vs. control; **p<0.01 vs. control; *** p<0.001 vs. control; A:B p=0.202; A:C  p<0.05; B:C p<0.001, 
y. =year 
Fig. 1. SOD values in different periods of illness in patients with DDSP as compared to the 
control group  
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Fig. 2. Erythrocite CAT values in different periods of illness in patients with DDSP as 
compared to the control group  * p<0.05 vs. control,  A:B   p<0.01; A:C  p=0.15;  B:C 
p=0.24, y.= year 
 
 
 
 
*** p<0.001 vs. control A:B   p=0.97; A:C  p=0.38;  B:C   p=0.28, y= year 
Fig. 3. GSH-PX values in different periods of illness in patients with DDSP as compared to 
the control group 
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Fig. 4. GSH values in erythrocytes in different periods of illness in patients with DDSP as 
compared to the control group    * p<0.05 vs. control     A:B   p=0.4  ;      A:C  p=0.5  ;     B:C   
p=0.9 , y= year 
There was statistically significant difference between the latency and amplitude of sensory 
evoked potentials (SEP) of medial plantar nerve in the patients and the controls (Tab. 3). 
 
 
 
SEP  
n.plantaris medialis 
Patients 
 mean± SD  
Controls 
 mean ± SD t p 
Latency [ms] 7.50 ± 1.36 5.56 ± 0.89 -8.90 <0. 0001 
Amplitude [µV] 0.381± 0.358 0.849 ± 0.606 5.37 <0. 0001 
 
 
 
Table 3. Latency and amplitude of the SEP of medial plantar nerve in the diabetic 
neuropathy patients and in the control 
All electrophysiological parameters related to the conduction of motor and sensory fibers of 
the tested upper and lower extremity nerves showed that there was a statistically significant 
difference between diabetic neuropathy patients and controls (Tab. 4). 
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ENG parameters 
Controls 
mean±SD 
Patients 
mean±SD t p 
CMAP  
peroneal nerve 
Latency (ms)  3.54±0.56 4.66±1.13 -6.64 <0. 0001 
Amplitude (mV)  5.77±2.47 3.46±2.13  5.88  <0. 0001  
NCV (m/s)  51.65±5.79 41.24±6.77  9.20  <0. 0001 
CMAP  
tibial nerve 
Latency (ms)  3.56±0.51 4.94±1.32  -7.13  <0. 0001 
Amplitude (mV)  11.19±4.73 4.62±2.98 10.28  <0. 0001 
NCV (m/s)  43.37±3.07 35.72±7.30  7.083 <0. 0001 
CMAP   
median nerve 
Latency (ms)  3.45±0.55 4.88±2.24 -4.47  <0. 0001  
Amplitude (mV)  7.00±2.51 4.90±2.35  5.23  <0. 0001 
NCV (m/s)  56.57±7.01 49.52±6.22 6.27  <0. 0001 
CMAP   
ulnar nerve 
Latency (ms)  2.90±0.63 3.17±0.78 -2.12  0. 0359 
Amplitude (mV)  7.87±3.35 4.93±7.27  6.36  0. 0025  
NCV (m/s)  57.54±8.57 48.59±8.00  6.30  <0. 001 
SEP  
sural nerve 
Latency (ms)  2.93±0.50 4.14±0.90  -8.60  <0. 0001 
Amplitude (mV)  15.61±6.16 8.79±5.77 6.31  <0. 0001 
NCV (m/s)  36.37±4.48 29.49±6.35 6.63  <0. 0001 
SEP  
median nerve 
Latency (ms)  3.96±0.49 4.70±0.82 -5.83  <0. 0001 
Amplitude (mV)  43.07±9.33 15.75±9.70 16.47  <0. 0001 
NCV (m/s)  47.36±5.63 38.77±7.85  6.86  <0. 0001 
SEP  
ulnar nerve 
Latency (ms)  3.28±0.68 4.12±0.82 -6.23  <0. 0001 
Amplitude (mV)  36.46±11.63 17.28±12.22 9.16  <0. 0001 
NCV (m/s)  46.32±6.10 38.20±7.37 6.69  <0. 0001 
Table 4. ENG parameters in the diabetic neuropathy patients and in the control group. 
CMAP – compound muscle action potential,  SEP - sensory evoked potentials, NCV-nerve 
conduction velocity 
A number of scored ENG parameters correlated significantly with erythrocyte SOD and 
CAT level in the patients studied  (Tab. 5 and Tab. 6).  
 
 
SEP of 
medial plantar nerve 
SOD CAT GSH-px GSH 
r p r p r          p r         p 
Latency  -0.1621 0.1071 -0.0488 0.6295 -0.1149   0.2550 -0.0492    0.6265 
Amplitude 0.0995 0.3248 0.2059 0.0399 0.0580    0.5564 -0.0570     0.5734 
Table 5. Correlation between SEP parameters of medial plantar nerve and parameters of OS 
(SOD and CAT) in diabetic neuropathy patients. Marked values point out a statistically 
significant correlation. 
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Nerve ENG parameters
SOD CAT GPx GSH 
r p r p r p r p 
CMAP  
Peroneal nerve 
Latency 
Amplitude 
MEP NCV 
-0.1096
-0.2526
-0.2633
0.2777
0.0112
0.0081
-0.1597
-0.2859
0.0199
0.1126
0.0039
0.8442
-0.0577
-0.1096
-0.1417
0.5683
0.2777
0.1598
-0.0605 
-0.0662 
0.0097 
0.5497 
0.5129 
0.9238 
CMAP  
Tibial nerve 
Latency 
Amplitude 
NCV 
-0.1866
-0.1575
-0.2524
0, 0630
0.1175
0.0113
0.0406
-0.0568
0.0254
0.6883
0.5747
0.8016
0.0130
-0.0233
-0.0910
0.8977
0.8184
0.3681
-0.0476 
0.0148 
0.0618 
0.6383 
0.8837 
0.5416 
CMAP  
Median nerve 
Latency 
Amplitude 
NCV 
-0.2326
-0.0663
-0.2171
0.0199
0.5123
0.0301
-0.0959
0.0188
0.0462
0.3425
0.8529
0.6483
-0.0694
-0.1198
-0.0469
0.4929
0.2352
0.6431
0.0140 
0.1366 
0.1887 
0.8901 
0.1753 
0.0601 
CMAP  
Ulnar nerve 
Latency 
Amplitude 
NCV 
-0.0442
-0.1531
-0.1387
0.6627
0.1282
0.1687
-0.0043
0.0174
-0.0629
0.9659
0.8639
0.5339
-0.1294
0.0327
-0.0694
0.1996
0.7466
0.4927
-0.0209 
0.0224 
-0.0655 
0.8366 
0.8252 
0.5174 
SEP 
Median nerve 
Latency 
Amplitude 
NCV 
-0.2183
-0.0881
-0.2079
0.0291
0.3836
0.0379
-0.0501
-0.0057
-0.0569
0.6205
0.9549
0.5741
-0.0771
0.0904
-0.1253
0.4456
0.3710
0.2143
-0.1923 
-0.1230 
-0.2805 
0.0552 
0.2227 
0.0047 
SEP 
Ulnar nerve 
Latency 
Amplitude 
NCV 
-0.1679
-0.0213
-0.1202
0.0949
0.8336
0.2336
-0.1659
-0.0997
-0.0627
0.0991
0.3239
0.5357
-0.0095
-0.0866
-0.1009
0.9252
0.3914
0.3178
-0.1094 
-0.1710 
-0.1344 
0.2786 
0.0889 
0.1826 
SEP 
Sural nerve 
Latency 
Amplitude 
NCV 
-0.1129
-0.2896
-0.1122
0.2636
0.0035
0.2662
-0.3837
-0.1449
-0.3840
0.0001
0.1505
0.0001
-0.0245
-0.0275
0.0035
0.8088
0.7861
0.9723
0.0443 
-0.0194 
0.0798 
0.6613 
0.8481 
0.4298 
Table 6. Correlation between ENG parameters and parameters of OS (SOD and CAT) in 
diabetic neuropathy patients. MEP- Motor Evoked Potential,  SEP- Sensory Evoked 
Potentials,  NCV – Nerve Conduction Velocity. Marked values point out a statistically 
significant correlation. 
6. Discussion 
Results of experimental studies,  conducted both in vivo and in vitro,  suggest that the 
peripheral nervous system is sensitive to oxidative damage (Schmeichel et al.,2003; Russel et 
al., 1999;Russel et al., 2002). Neurons take over glucose from the blood by the concentration 
dependent transport,  so that hyperglycemia is always associated  with increased glucose 
values in the neurons,  which results in oxidative stress (Tomlinson and Gardiner,2008; 
Andrea et al.,2004). On the other hand,  antioxidative defense in peripheral nerves is 
thought to be limited due to primary lower values of glutathione and glutathione-
dependent enzymes (GSH-Px and GSH-r)  (Romero et al., 1991; Schmeichel et al.,2003),  
which further increases the sensitivity of nerves to oxidative damage. SOD could provide 
efficient antioxidative protection,  since,  contrary to glutathione-dependent enzymes,  it is 
relatively more active in the peripheral nerves. However,  in spite of such a theoretical 
position,  studies carried out on experimental models have not shown any significant 
changes of the endoneural antioxidative status in the experimentally induced DN, except an 
increased CAT levels which could not be able to correct by insulin therapy (Van Dam et al., 
1996). On the other side,  positive effects of antioxidants on the antioxidative capacity of 
blood, and also on the disturbed function of peripheral nerves in the very same 
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experimental models,  lead one to conclude that systemic OS can have a more significant 
role compared to endoneural OS in the development of neuropathic changes. 
The determination of OS biomarkers is an important step in the understanding of DN 
pathogenesis. Recent research suggests that there are tissue- and time-dependent changes in 
the activity of various antioxidative enzymes. The results of our study show that there is a 
statistically significant reduction of erythrocyte SOD levels in patients with type 2 DM and 
DDSP in comparison with healthy controls,  which corresponds to the data from the 
literature (Arai et al., 1987; Kawamura et al., 1992; Vijaylingam et al., 1996). Eerythrocyte 
SOD level was significantly lower in patients with diabetic neuropathy compared with 
patients without diabetic neuropathy, suggesting the importance of antioxidant protection 
in the prevention of nerve injury. The main reason for the reduced SOD activity is the 
glycolization of Cu, Zn-SOD,  which has been documented in both in vitro and in vivo 
experiments (Arai et al., 1987; Kawamura et al., 1992). However,  there are also studies 
which show no changes in erythrocyte SOD activity (Peuchant et al.,1997; Walter et al.,1991; 
Faure et al.,1995),  or which,  quite the contrary,  suggest an increased activity of this 
enzyme (Yaqoob et al., 1994). 
In most cases,  CAT activity in erythrocytes was not changed in either experimental animals 
or type 1 and type 2 DM patients (Wohaieb & Godi, 1987; Godin et al., 1988; Matkovich et 
al., 1982). However,  some studies have noted changes in CAT activity,  in particular its 
reduction (Vijaylingam et al., 1996; Alphonsus et al., 2007). In this study,  erythrocyte CAT 
values were reduced in patients as compared with the controls,  but this reduction did not 
reach statistically significant levels,  which correlates with the literature data listed above. 
Catalase values were reduced in patients with DSP, compared with patients without DSP, 
although these deviations were not statistically significant. Reduced CAT activity could be 
explained by the accumulation of H2O2 in the cells, as a result of glucose autooxidation. As 
the principal enzymatic role of CAT is to control H2O2 concentration,  H2O2 accumulation in 
the cells is believed to lead to the exhaustion of this enzyme,  which primarily reflects 
erythrocytes,  where CAT is otherwise most active. Studies have shown that in other tissues 
H2O2 accumulation may stimulate CAT synthesis, thus increasing its activity. However, 
erythrocytes lack the genetic apparatus for such a synthesis, which is a reason that the 
increased H2O2 concentration results in the exhaustion and inactivation of catalase 
(Alphonsus et al., 2007). 
Changes in the activity of glutathione-dependent enzymes were different in experimental 
models. Most studies have shown tissue and time dependent changes of enzyme activity. 
However, even if we acknowledge these factors, we cannot precisely match the results of 
various studies of the association of DM and activity of glutathione-dependent enzymes. 
The studies dealing with the GSH-Px activity in the erythrocytes have demonstrated 
variable results. A large number of studies demonstrated that GSH-Px activity in the blood, 
erythrocytes, and leukocytes was similar in DM patients (types 1 and 2) and in healthy 
controls (Walter RM et al., 1991; Leonard M.B. et al., 1995; Akkus I et al., 1996). On the other 
hand, there are studies clearly confirming altered activity of glutathione-dependent 
enzymes in DM, above all in the form of reduced activity of GSH-Px and increased activity 
of GSH reductase (Godin et al., 1988; Dohi et al.,1988; Tagami et al., 1992; Langenstroer & 
Pieper, 1992; Blakytny and Harding,1992). Murakami (1991), studying the erythrocytes in 
DM, concluded that reduced erythrocyte GSH was caused by reduced activity of gamma 
glutamyl-cystein synthetase in connection with its glycation, reduced activity of GSH-
www.intechopen.com
The Role of Oxidative Stress in Pathogenesis of Diabetic Neuropathy: Erythrocyte  
Superoxide Dismutase, Catalase and Glutathione Peroxidase Level in Relation to....  
 
169 
reductase and defective glutathione transport. Yoshida  (1995) confirmed that in the 
erythrocytes of diabetics with poorly controlled disease the synthesis of GSH and thiol 
transport were damaged, rendering the cells more sensitive to oxidative damage. In 
diabetics with permanently higher values of glucose Uzel et al. (1987) established reduced 
GSH-Px activity and lower erythrocyte GSH values, with increased products of lipid 
peroxidation, with changes more apparent in patients with retinopathy. GSH reduction in 
the erythrocytes in DM was confirmed by Bono et al. (1987) as well. Stahlberg and Hietanen 
(1991) observed a reduced activity of GSH reductase in children with DM but Walter  et al. 
(1991) were not able to demonstrate any difference in GSH-Px and GSH reductase activities 
in diabetics and nondiabetics. Kaji et al. (1985) failed to find a difference in activity of 
erythrocyte GSH-Px, but established increased GSH-Px activity in the plasma in women 
with DM. Osterod et al. (1996) found in their studies a reduced erythrocyte GSH-Px activity 
in DM type 1. Authors of some studies also described an increased erythrocyte GSH-Px 
activity in DM (Matkovics et al., 1982). Literature data mostly indicated an unaltered or 
reduced activity of erythrocyte GSH-Px. The results obtained in this study indicate a 
statistically significant reduction of GSH-Px activity both in patients with DSP and in 
patients without DSP, compared to controls. Erythrocyte GSH-Px values were significantly 
lower in patients with diabetic neuropathy compared with patients without diabetic 
neuropathy. Reduced GSH-Px could be directly explained by reduced GSH content in 
studied patients, representing otherwise a substrate and cofactor for GSH-Px enzyme.  
The studies of glutathione homeostasis in DM have so far shown tissue differences in the 
levels of GSH, although in most of the cases reduced GSH contents have been found. The 
studies of glutathione level in the blood of diabetics demonstrated that those with DM type 
2 had reduced erythrocyte level of GSH and increased level of GSSG (De Mattia at all, 1994; 
Jain & McVie, 1994). The blood level of GSH was significantly reduced in various phases of 
the type 2 DM, such as glucose intolerance, early hyperglycemia (Vijayalingam et al., 1996) 
in the first two years and before complications developed (Sundaram et al., 1996), as well as 
in poorly controlled glycemia (Peuchant et al., 1997). Yoshida et al. (1995) observed reduced 
GSH in the erythrocytes of type 2 diabetics, with disturbed activity of gamma glutamyl 
transferase and thiol transport. In contrast to a clear reduction of blood GSH in type 2 DM, 
in type 1 disease the results were not entirely convincing. The role of GSH in the occurrence 
of diabetes complications has not been elucidated. Thornalley et al. (1996) found an inverse 
correlation between the level of erythrocyte GSH and presence of diabetes complications 
(neuropathy, retinopathy, and nephropathy) in patients with DM type 1 and 2, leaving 
unanswered the question whether GSH levels were reduced in those without complications, 
ot these patients have an even more significant reduction GSH levels. 
The results of our investigation showed a statistically significant reduction of erythrocite 
GSH level both in patients with DSP and in patients without DSP compared to controls, 
which was in accordance with the literature data. In the group of patiens without DSP, 
erythrocite GSH-Px value did not show larger deviations compared to patients with DSP.  
Some studies of the antioxidative protection system in DM, principally in experimental 
animal models, were related to the study of impact of disease duration on the activity of 
antioxidative enzymes. Time-dependent changes of the activity of antioxidative enzymes 
and prooxidative-antioxidative balance were thus observed in DM in various tissues. 
(Majythija & Jayesh, 2005; Sasvári and Nyakas, 2003). Kishi et al.(2005) based on their own 
study, came to the conclusion that changes in the activity of antioxidative enzymes in 
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peripheral nerves were not the result of reduced gene expression, but can be linked to the 
duration of DM or posttranslational modifications. 
Bearing these information in mind, this study analyzed the activity of antioxidative enzymes 
and glutathione in the blood of patients which disease had lasted up to 5 years, 5-15 years, 
and over 15 years. The activity of SOD enzyme was generally lower in patients in each 
phase of the disease, though the reduction was variable. The smallest reduction was 
observed in the first 5 years of DM, while the reduction was most evident in advanced 
disease phases - in those affected for more than 15 years. More intense inactivation of SOD 
in more advanced DM could be explained by increased production of H2O2 in the processes 
of non-enzymatic glycation predominating with time, which can further inhibit SOD. In the 
group of those affected for 5-15 years, a slight increase of SOD activity can be observed 
related to other two groups, which can be explained by an adaptive increase of antioxidative 
protection pathways. Increased H2O2 production inhibited SOD activity, but, on the other 
hand, formation of superoxide radicals presents a signal for increased gene expression of 
SOD (Matsuyama et al. 1993). Available amount and activity of SOD should represent a 
balance between the enzyme production and its degradation. As shown here, the balance 
demonstrated time-dependent modulation in different disease phases. 
The activity of erythrocyte catalase also demonstrated a declining tendency, with the 
smallest decline in the first 5 years of DM. The decline of catalase activity was greatest in 
those affected for 5-15 years. In this group, the values of erythrocyte catalase were 
significantly different from control ones. 
In all groups, a statistically significant reduction of erythrocyte GSH level was observed 
compared to controls. Among the groups of different disease phases, there was no 
statistically significant difference in the erythrocyte GSH level. 
Changes were observed also with the enzyme associated with glutathione metabolism – 
GSH-Px. This enzyme demonstrated a statistically significant decline of activity in all 
disease phases compared to controls. The decline was most evident in advanced DM (>15 
years), though there were no statistically significant deviations among the individual groups 
of patients in different disease phases. Reduced GSH-Px activity can be directly explained 
by low GSH content in diabetics, in view of the fact that GSH is the substrate and cofactor of 
GSH-Px. Reduced GSH-Px activity can be caused by the enzyme inactivation as the 
consequence of increased glycation in the situation of hyperglycemia. Increased glycation 
and consequential protein reactions can affect amino acids in active enzyme domain or 
disturb stereochemical configuration and cause structural and functional molecular changes 
(Bonnefont-Rousselot et al., 2000). Reduced GSH-Px activity causes H2O2 accumulation, 
which also contributes to progressive reduction of activity of SOD in advanced DM. 
These changes in the activity of antioxidative enzymes in DM confirm the notion that 
disturbed carbohydrate metabolism have an impact on the function of antioxidative 
protection which by itself can affect the development of late complications of DM. In recent 
years, it has been definitely confirmed that the frequency of late diabetic complications is 
higher with poorer metabolic control. If oxidative stress has a role in the development of 
diabetic complications, we should expect adaptive changes in the system of antioxidative 
protection. These changes would be more or less evident in different situations of metabolic 
control and largely depend on the duration of unfavorable metabolic status. 
Similarly to the literature data, our results suggest that blood of type 2 DM patients has 
decreased antioxidative protection. However,  in spite of strong evidence in the literature 
that OS is increased in DM,  there is still no definite connection between OS levels and the 
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development of late diabetic complications. Accordingly,  in this study,  we have looked 
into the interrelation between the tested antioxidative enzyme levels and the functional 
damage of peripheral nerves. Our previous study did not show any correlation between 
plasma total antioxidant capacity (TAC) and the degree of damage of peripheral nerves in 
type 2 DM and DDSP patients (Djordjević et al., 2008). Having in mind  that TAC is not a 
mere sum of various antioxidant activity,  but a dynamical system of interdependent 
individual serum antioxidant parameters (Koraćević et al., 2001),  we have designed this 
study in such a way as to observe and analyze the influence of individual TAC constituents 
on the development of peripheral nerve dysfunction in type 2 DM patients.  
All electroneurographic parameters of peripheral nerve conduction have showed deviation 
in the patients as compared with the control group and these deviations have been 
statistically significant. In the studied patients,  we have found a significant negative linear 
correlation between erythrocyte SOD levels and a number of scored ENG parameters – 
indicators of  DDSP (the lower the SOD values,  the higher the ENG score,  i.e. the more 
pronounced the functional damage). The correlation that was found between SOD and ENG 
indicators of the degree of neuronal damage indicates that there was an important role of 
toxic effects of superoxide anion radicals in the development of neuronal damage. In vivo,  
superoxide anion radicals are mostly removed enzymatically, by SOD. When superoxide 
anion radicals are excessively produced,  they react with nitric oxide and form a 
peroxynitrite, which has numerous cytotoxic effects. A tenfold increase in superoxide anion 
radicals and nitric oxide has been found to increase peroxynitrite production one hundred 
times (Djordjević et al.,2000). Excessive production of superoxide anion radicals, nitric oxide 
and peroxynitrite may,  thus,  be a significant pathogenetic factor for neuronal damage.  
As for catalase,  even though the reduced activity of this enzyme did not reach statistical 
significance in this study,  the correlation analysis between CAT blood levels and the 
electrophysiological conduction parameters of the peroneal,  sural,  median,  and plantar 
nerves (MEP-amplitude of peroneal nerve,  the latency and NCV of the sural nerve,  the SEP 
amplitude of medial plantar nerve) has revealed a statistically significant value. Such results 
suggest that CAT has a pathogenetic importance,  i.e. that hydrogen peroxide has toxic 
effects on the degree of neuronal damage.  
There was no correlation between erythrocite GSH-Px and ENG parameters which could be 
explained by lower Km and lower GSH-Px activity in erythrocytes, compared to CAT 
activity. Erythrocite GSH-Px value correlated with censory nerve condaction of median 
nerve only. This results could be explained by limited activity of GSH and GSH-dependent 
enzymes in periferal nerves. It should also bear in mind that the values of GSH and GSH-px 
in our group of patients showed small variation over the course of DM, which could also be 
the explanation for the lack of correlation with the ENG parameters, given the progressive 
course of diabetic neuropathy.  
7. Conclusion 
DM is closely linked to an imbalance in pro/antioxidant status of cells and changes in redox 
potential. Oxidative stress, as a common denominator, is the biochemical mechanism by 
which disturbed glucose metabolism and deregulation of cell signaling leads to the 
development of diabetic complications. Results of our study pointed out a reduced systemic 
antioxidative defense in the patients with type 2 DM and diabetic distal symmetrical 
polyneuropathy and indicate that systemic oxidative stress plays a potential role in the 
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development of diabetic neuropathy. For better understanding of the role of oxidative stress 
and antioxidative mechanisms, further investigations with standardized methodology, 
molecular biological technique and better defined experimental models and subjects are 
required, aiming to prevent, delay or slow the progression of the disease. 
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